Table 6.
Difference in mean screening interval for cervical cancer screening program (2020 versus 2019, Flanders)
| January, 1 (week 1)– December,31 (week 52) | January, 1 (week1)-March 21 (week 11) | March, 22 (week 12)- May, 23 (week 20) | May, 24 (week 21) December, 31 (week52) | |
|---|---|---|---|---|
| (entire year) | (before COVID-19 shutdown) | (during COVID-19 shutdown) | (after restart of the program) | |
| months (95% CI) | months (95% CI) | months (95% CI) | Months(95% CI) | |
| All women screened | -0.3 (-0.2; -0.4) | -0.1 (-0.2; 0.1) | -2.3 (-2.1; -2.6) | -0.3 (-0.5; -0.2) |
| Stratified by age | ||||
| 25–29 | 0.1 (-0.1; 0.3) | 0.3 (-0.1; 0.8) | -1.2( -1.9; -0.0) | 0.0 (-0.3; 0.3) |
| 30–34 | -0.1 (-0.3; 0.1) | 0.4 (0.0; 0.8) | -1.8 (-2.4; -1.1) | -0.3 (-0.6; -0.1) |
| 35–39 | 0.0 (-0.2; 0.2) | 0.5 (0.1; 0.9) | -1.6 (-2.3; -0.9) | -0.2 (-0.5; 0.1) |
| 40–44 | -0.2 (-0.4; 0.0) | -0.3 (-0.7; 0.1) | -2.0 ( -2.7; 1.3) | -0.2 (-0.5; 0.1) |
| 45–49 | -0.3 (-0.5; -0.1) | -0.6 (-1.0; -0.2) | -2.4 (-3.0; -1.7) | -0.1 (-0.4; 0.2) |
| 50–54 | -0.6 (-0.8; -0.4) | -0.5 (-0.9; -0.1) | -3.4 (-4.1; -2.7) | -0.5 (-0.2; -0.7) |
| 55–59 | -0.7 (-1.0; -0.5) | -0.4 (-0.8; 0.0) | -3.3 (-4.0; -2.6) | -0.9 (-1.2; -0.6) |
| 60–64 | -0.5 (-0.8; -0.2) | 0.0 (-0.5; 0.5) | -2.8 (-3.7; -1.9) | -0.7 (-1.0; -0.4) |